
Feb 25 (Reuters) - GE Healthcare Technologies Inc GEHC.O:
PATIENTS IN THE US UNDERGO FIRST DOSES OF GE HEALTHCARE’S NEW PET RADIOTRACER, FLYRCADO (FLURPIRIDAZ F 18) INJECTION
GE HEALTHCARE TECHNOLOGIES INC - FLYRCADO EXPECTED TO BE AVAILABLE AT MOST CARDIAC PET CENTERS BY 2025
GE HEALTHCARE TECHNOLOGIES INC - FULL COMMERCIALIZATION OF FLYRCADO ANTICIPATED IN Q2 2025
Source text: ID:nBw6WSqfsa
Further company coverage: GEHC.O